Stuart L. Goldberg

Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy

Andreas Hochhaus, Hagop M. Kantarjian, Michele Baccarani et al. · Blood · 2006 · 609 citations · Full text

Medicine, Hematology, Oncology +14

Phase I Trial of Intravenous Administration of PV701, an Oncolytic Virus, in Patients With Advanced Solid Cancers

Andrew L. Pecora, Naiyer A. Rizvi, Gary I. Cohen et al. · Journal of Clinical Oncology · 2002 · 389 citations

Pharmacy, Oncology, Pharmacology +9

BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia

Matthew S. Zabriskie, Christopher A. Eide, Srinivas K. Tantravahi et al. · Cancer Cell · 2014 · 366 citations · Full text

Medicine, Molecular Biology, Oncology +7

Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib

Andreas Hochhaus, Michele Baccarani, Michael W. Deininger et al. · Leukemia · 2008 · 354 citations

Medicine, Hematology, Oncology +13

Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study

Noa Biran, Andrew Ip, Jaeil Ahn et al. · The Lancet Rheumatology · 2020 · 296 citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +7